Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | 10.0 | n/a |
Op Mrgn | 7.4% | n/a |
ROCE | 19.9% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | 5.4% | n/a |
PBT | -7.4% | n/a |
EPS | -3.8% | n/a |
DPS | 6.7% | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-21 | 510.10 | 33.10 | 75.10p | 32.2 | 0.4 | +79% | 6.50p | 0.3% |
30-Jun-22 | 554.20 | 36.00 | 85.80p | 19.3 | 1.4 | +14% | 7.00p | 0.4% |
30-Jun-23 | 588.90 | 60.70 | 98.90p | 20.0 | 1.3 | +15% | 7.50p | 0.4% |
30-Jun-24 | 638.70 | 35.20 | 83.30p | 12.1 | n/a | -16% | 7.50p | 0.7% |
30-Jun-25 | 673.20 | 32.60 | 80.10p | 15.6 | n/a | -4% | 8.00p | 0.6% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Final results for the year ended 30 June 2025 | 07-Oct-2025 | 07:00 | RNS |
Total Voting Rights | 30-Sep-2025 | 07:00 | RNS |
PDMR Shareholding Correction | 15-Sep-2025 | 16:50 | RNS |
Vet chain’s £40m for acquisitions | 22-Dec-2011 | The Scotsman |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1,378.00p |
Change Today | 128.00p |
% Change | 10.24 % |
52 Week High | 1,398.00p |
52 Week Low | 798.00p |
Volume | 434,131 |
Shares Issued | 71.74m |
Market Cap | £988.58m |
RiskGrade | 136 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 06-Nov-25 | 31-Oct-24 |
Paid | 05-Dec-25 | 29-Nov-24 |
Amount | 8.50p | 8.00p |
Time | Volume / Share Price |
13:06 | 64 @ 1,378.00p |
13:05 | 5 @ 1,380.00p |
13:05 | 35 @ 1,380.00p |
13:04 | 42 @ 1,380.00p |
13:04 | 17 @ 1,380.00p |
CEO | Richard Fairman |
Finance Director | Robin Alfonso |
You are here: research